Calliditas Therapeutics AB (0A5R.LSE) Q4 2023 Earnings

Feb 21Confirmed
Q4 2023
-0.97
-0.76
-0.55
-0.35

Details

Expected EPS
-0.965310949522206
Actual EPS
-0.34755148092
Surprise EPS
0.62
Surprise Percent
+64%

Description

⁨Calliditas Therapeutics AB⁩ (⁦0A5R.LSE⁩) has reported earnings of ⁦-0.34755148092⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts